Planned birth at 39 weeks in low-risk nulliparous women: mapping international evidence to India's national health mission framework
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20263080Keywords:
Elective induction of labor, 39 weeks gestation, Cesarean section, National Health Mission, Perinatal mortality, IndiaAbstract
Global obstetric practice has shifted over the past decade from routine expectant management of low-risk term pregnancies toward active consideration of planned birth at 39 weeks, while India's public health system has, over the same period, achieved substantial gains in institutional delivery, antenatal coverage, and high-risk pregnancy tracking under the National Health Mission (NHM). This review synthesizes the international evidence for planned 39-week birth in low-risk nulliparous women, examines the small emerging Indian evidence base, weighs areas of continuing debate around implementation and external validity, and maps the resulting picture onto the operational architecture of PMSMA, LaQshya, and SUMAN. International randomized and cohort evidence consistently favors planned 39-week birth, with reduced caesarean delivery and reduced hypertensive disorders of pregnancy; the largest available cohort found a substantial reduction in perinatal mortality for planned birth overall, though this benefit was driven predominantly by scheduled caesarean rather than induction specifically. Two Indian trials identified to date, both small, point in the same direction as the international literature and do not show any caesarean-increasing effect of induction. Real-world implementation data complicate a purely reassuring picture, raising legitimate questions about indication creep, external validity, and systemic workload. The more consequential India-specific finding is infrastructural rather than physiological: national first-trimester registration has risen sharply, but this reflects administrative registration rather than confirmed dating ultrasound, making gestational-age precision the central prerequisite for any 39-week protocol in India. A phased approach, gated on confirmed dating and supported by prospective audit, offers a measured pathway for evaluating this practice in the Indian context.
References
Grobman WA, Rice MM, Reddy UM, Tita ATN, Silver RM, Mallett G, et al. Labor induction versus expectant management in low-risk nulliparous women. N Engl J Med. 2018;379(6):513-23.
Ministry of Health and Family Welfare, Government of India; International Institute for Population Sciences. National Family Health Survey-6 (NFHS-6), 2023-24: Fact Sheets. New Delhi: MoHFW; 2026.
Sample Registration System (SRS) 2021-23, Registrar General of India. Special Bulletin on Maternal Mortality in India. Available at: https://censusindia.gov.in/nada/index.php/catalog/46177. Accessed on 15 May 2026.
Middleton P, Shepherd E, Morris J, Crowther CA, Gomersall JC. Induction of labour at or beyond 37 weeks' gestation. Cochrane Database Syst Rev. 2020;7(7):CD004945.
El-Sayed YY, Rice MM, Grobman WA, Reddy UM, Tita ATN, Silver RM, et al. Elective labor induction at 39 weeks of gestation compared with expectant management: factors associated with adverse outcomes in low-risk nulliparous women. Obstet Gynecol. 2020;137(3):455-62.
Grobman WA, Caughey AB. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies. Am J Obstet Gynecol. 2019;221(4):304-10.
Crawford K, Carlo WA, Odibo A, Papageorghiou A, Tarnow-Mordi W, Kumar S. Perinatal mortality and other severe adverse outcomes following planned birth at 39 weeks versus expectant management in low-risk women: a population based cohort study. EClinicalMedicine. 2025;80:103076.
American College of Obstetricians and Gynecologists. Practice Advisory: Clinical guidance for integration of the findings of the ARRIVE trial: labor induction versus expectant management in low-risk nulliparous women. Washington, DC: ACOG; 2018.
Society for Maternal-Fetal Medicine (SMFM) Publications Committee. SMFM statement on elective induction of labor in low-risk nulliparous women at term: the ARRIVE trial. Am J Obstet Gynecol. 2019;221(1):B2-4.
Lalithadevi P, Rengaraj S, Dasari P, Adhisivam B. Elective induction of labor versus expectant management at 39 weeks among low-risk nulliparous pregnant women: a randomized controlled trial in India (ELITE-39 trial). Int J Gynecol Obstet. 2024;167(1):427-33.
Aakanksha, Kumari A, Tirkey S. Elective induction of labour at 39 weeks in low-risk nulliparous women versus expectant management: a pilot randomized control trial. Int J Reprod Contracept Obstet Gynecol. 2026;15(2):610-7.
Lim SS, Dandona L, Hoisington JA, James SL, Hogan MC, Gakidou E. India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation. Lancet. 2010;375(9730):2009-23.
Ministry of Health and Family Welfare, Government of India; International Institute for Population Sciences. National Family Health Survey-5 (NFHS-5), 2019-21: Fact Sheets. New Delhi: MoHFW; 2021.
Ministry of Health and Family Welfare, Government of India. Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA): programme overview. Available at: https://pmsma.mohfw.gov.in/. Accessed on 04 July 2026.
Ministry of Health and Family Welfare, Government of India. LaQshya: Labour Room Quality Improvement Initiative — operational guidelines. New Delhi: MoHFW, National Health Mission. Available at: https://nhm.gov.in/index1.php?lang= 1&level=3&sublinkid=1307&lid=690. Accessed on 04 July 2026.
Ministry of Health and Family Welfare, Government of India. Surakshit Matritva Aashwasan (SUMAN) — operational guidelines. New Delhi: MoHFW, National Health Mission. Available at: https://www. myscheme.gov.in/schemes/suman. Accessed on 04 July 2026.
Sengupta S, Carrion V, Shelton J, Wynn RJ, Ryan RM, Singhal K, et al. Adverse neonatal outcomes associated with early-term birth. JAMA Pediatr. 2013;167(11):1053-9.
Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, Hoffman M, et al. Respiratory morbidity in late preterm births. JAMA. 2010;304(4):419-25.
Robson MS. Classification of caesarean sections. Fetal Matern Med Rev. 2001;12(1):23-39.
World Health Organization. WHO Statement on Caesarean Section Rates. Geneva: WHO; 2015. Available at: https://www.who.int/publications/i/ item/WHO-RHR-15.02. Accessed on 04 July 2026.
Vogel JP, Betrán AP, Vindevoghel N, Souza JP, Torloni MR, Zhang J, et al. Use of the Robson classification to assess caesarean section trends in 21 countries: a secondary analysis of two WHO multicountry surveys. Lancet Glob Health. 2015;3(5):e260-70.
Spandana S, Shivanna AK. The ten group Robson classification: a retrospective study to identify strategies to optimise caesarean section rates. Int J Reprod Contracept Obstet Gynecol. 2020;9(12):5082-6.
Vogel JP, Pujar Y, Vernekar SS, Armari E, Pingray V, Althabe F, et al. Effects of the WHO Labour Care Guide on cesarean section in India: a pragmatic, stepped-wedge, cluster-randomized pilot trial. Nat Med. 2024;30:463-9.
Attali I, Cormier J, Goffinet F, Le Ray C. Does induction of labor without a medical indication explain the overall increase in the induction rate: an observational study before and after the ARRIVE trial. BMC Pregnancy Childbirth. 2025;25:349.
Wood R, Freret TS, Clapp M, Little S. Rates of induction of labor at 39 weeks and cesarean delivery following publication of the ARRIVE trial. JAMA Netw Open. 2023;6(8):e2328274.
Azria E, Haaser T, Schmitz T, Froeliger A, Bouchghoul H, Madar H, et al. The ethics of induction of labor at 39 weeks in low-risk nulliparas in research and clinical practice. Am J Obstet Gynecol. 2024;230(3):S775-82.
Einerson BD, Nelson RE, Sandoval G, Esplin MS, Branch DW, Metz TD, et al. Cost of elective labor induction compared with expectant management in nulliparous women. Obstet Gynecol. 2020;136(1):19-25.
Daftary SN, Desai SV, Thanawala U, Bhide A, Levi J, Patki A, et al. Programmed labor—indigenous protocol to optimize labor outcome. J South Asian Fed Obstet Gynaecol. 2009;1(1):61-4.
Downloads
Published
How to Cite
Issue
Section
